October 2017

Nicholas A. Peppas

Professor Nicholas A. Peppas is the Cockrell Family Regents Chair in Engineering with appointments in the Departments of Biomedical and Chemical Engineering, the Departments of Pediatrics and Surgery of the Dell Medical School and the Division of Molecular Pharmaceutics and Drug Delivery of The University of Texas at Austin. Dr. Peppas has had a 49-year career in the field of pharmaceutical sciences and drug delivery. He is a member of the National Academy of Engineering, National Academy of Medicine, American Academy of Arts and Sciences, and the European,...Read more

Read more about Nicholas A. Peppas

Bill Kaemmerer

Neuroscientist with extensive experience in the delivery of AAV to the brain. Available for consulting or contractual assignments. I am particularly passionate about advancing and facilitating the development of DNA-based therapies for Huntington’s disease and other neurological disorders into Phase I clinical trials. For this reason, I co-founded the not-for-profit CGTA Research Group.

My experience includes developing strategic programs of research and serving as a leader of a team of Ph.D. and Master's level scientists using molecular biology, in vitro cell culture,...Read more

Read more about Bill Kaemmerer

Paul Burke

Paul Burke is Principal of Burke Bioventures LLC, a biotechnology consultancy providing strategic advice and scientific direction for biotechnology, pharmaceutical, and drug delivery companies, with a particular focus on nanotechnology, targeting, and RNA. Dr. Burke brings two decades of biopharmaceutical industry experience, having served in executive roles at Amgen, Merck, and Pfizer where he specialized in launching and directing new technology initiatives for transforming discovery and preclinical pipelines. He received his PhD in Biological Chemistry from the Massachusetts...Read more

Read more about Paul Burke

Arindam Bose

Arindam Bose is currently an Independent Consultant in biologics process development and manufacturing following a 35-year career in bioprocess development, clinical supply manufacturing, external partnering, corporate biotechnology strategy and advocacy for science-based regulations for biologics at Pfizer Worldwide R&D. He served as the Technical Lead of the Team that developed and executed Pfizer’s strategy for entry into the field of biosimilar medicines. Dr. Bose is a Member of the US National Academy of Engineering. Additionally, he was elected Fellow of AIChE, American Chemical...Read more